A patient is to receive medroxyprogesterone (Depo-Provera) 700 mg weekly, intramuscularly, as part of palliative therapy
Posted: Wed May 18, 2022 7:49 pm
A patient is to receive medroxyprogesterone (Depo-Provera) 700
mg weekly, intramuscularly, as part of palliative therapy for
endometrial cancer. The medication is available in vials of 400
mg/mL. Identify how many milliliters will the nurse draw up and
administer with each injection. (round answer to 1st decimal
place)
mg weekly, intramuscularly, as part of palliative therapy for
endometrial cancer. The medication is available in vials of 400
mg/mL. Identify how many milliliters will the nurse draw up and
administer with each injection. (round answer to 1st decimal
place)